Incidence of COVID-19 Infections Low in Vaccinated Health Care Workers
The incidence of infection is markedly reduced once health care workers receive the second dose of an mRNA COVID-19 vaccine regimen.
Lung Infections
FDA to Decide “Quickly” on Pfizer Request to Approve COVID-19 Vaccine for Children 12 to 15
The Pfizer request to expand EUA of its COVID-19 vaccine to include children ages 12 to 15 years will be evaluated “as quickly as possible.”
Blood Clot Risk Increased Following COVID-19 Hospitalization
Postdischarge, thromboprophylaxis was prescribed in 13.2 percent and the composite primary outcome rate was 7.13 percent.
FDA Launches Adverse Event Reporting Dashboard for Authorized COVID-19 Therapeutics
Data will be reported to the FDA by the pharmaceutical industry, health care providers, and consumers.
Antibody Cocktail May Lower Risk of Infection in Unvaccinated Individuals Exposed to COVID-19
People living with someone who has COVID-19 appear to get powerful protection against infection when they are given the Regeneron antibody cocktail.
Fake COVID-19 Vaccination Cards Being Sold Online
Fake COVID-19 vaccination cards are being sold online at sites such as eBay, Etsy, and Shopify, and bogus ads for the cards are appearing on Facebook.
Skin Reactions Usually Mild After COVID-19 Vaccination
The researchers report that from December 2020 to February 2021, there were 414 cutaneous reactions to mRNA COVID-19 vaccines.
Dialysis Patients Develop Decreased Antibody Response to Pfizer COVID-19 Vaccine
Most patients with kidney failure undergoing regular dialysis develop a substantial antibody response after receiving the Pfizer-BioNTech COVID-19 vaccine.
Lung Function Impairments in COVID-19 Survivors Who Received Mechanical Ventilation
A high prevalence of lung function and functional impairments has been reported among survivors of COVID-19 who required mechanical ventilation.
Trial Evaluating Allergic Reactions to Moderna, Pfizer-BioNTech COVID-19 Vaccines Begins
The phase 2 Systemic Allergic Reactions to SARS-CoV-2 Vaccination trial will enroll 3400 adults aged 18 to 69 years.
-
Loading...
-
Loading...
Next post in Lung Infection
